|
⚲
|
| Keyboard |
| Chang Nancy T
✚
|
|
|---|---|
| CIK # | 0001135041 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001135041] | |
| 4 | [0001135041] | |
| SC 13D | [0001135041] | |
| SC 13G | [0001135041] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Chang Nancy T | Galera Therapeutics Inc | [2026-04-10] |
| Chang Nancy T | Diamedica Therapeutics Inc | [2019-02-01] |
| Chang Nancy T | Applied Optoelectronics Inc | [2014-02-13] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| W&T Offshore Inc | |
| Chang Nancy T | |
| Immix Biopharma Inc | |
| Galera Therapeutics Inc | |
| MoonLake Immunotherapeutics | |
| Sciclone Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Immix Biopharma Inc IMMX
Stock Option (Right to Buy) · derivative
|
2025-11-21 | Grant | 39,643 | $0.00 | |
|
W&T Offshore Inc WTI
Restricted Stock Units · derivative
|
2025-06-03 | Grant | 103,448 | $0.00 | |
|
W&T Offshore Inc WTI
Restricted Stock Units · derivative
|
2025-06-03 | Option exercise | 73,892 | $0.00 | |
|
W&T Offshore Inc WTI
Common Stock
|
2025-06-03 | Option exercise | 73,892 | ||
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2025-02-24 | Grant | 96,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-12-30 | Buy | 7,644,932 | $0.07 | 535,145 |
|
Galera Therapeutics Inc GRTX
Series B Preferred Stock · derivative
|
2024-12-30 | Grant | 1,841.92 | $0.00 | |
|
W&T Offshore Inc WTI
Common Stock
|
2024-06-17 | Option exercise | 38,760 | ||
|
W&T Offshore Inc WTI
Restricted Stock Units · derivative
|
2024-06-17 | Option exercise | 38,760 | $0.00 | |
|
W&T Offshore Inc WTI
Restricted Stock Units · derivative
|
2024-06-14 | Grant | 73,892 | $0.00 | |
|
W&T Offshore Inc WTI
Restricted Stock Units · derivative
|
2023-07-03 | Grant | 38,760 | $0.00 | |
|
Sciclone Pharmaceuticals Inc SCLN
Non-Qualified Stock Option (right to buy) · derivative
|
2017-10-13 | Disposed to issuer | 30,000 | $2.03 | 60,900 |
|
Sciclone Pharmaceuticals Inc SCLN
Common Stock
|
2017-10-13 | Disposed to issuer | 70,000 | $11.18 | 782,600 |
|
Sciclone Pharmaceuticals Inc SCLN
Non-Qualified Stock Option (right to buy) · derivative
|
2017-10-13 | Disposed to issuer | 30,000 | $0.28 | 8,400 |
|
Sciclone Pharmaceuticals Inc SCLN
Non-Qualified Stock Option (right to buy) · derivative
|
2017-06-08 | Grant | 30,000 | $0.00 | |
|
Sciclone Pharmaceuticals Inc SCLN
Non-Qualified Stock Option (right to buy) · derivative
|
2016-09-29 | Option exercise | 33,333 | $0.00 | |
|
Sciclone Pharmaceuticals Inc SCLN
Non-Qualified Stock Option (right to buy) · derivative
|
2016-09-29 | Option exercise | 7,648 | $0.00 | |
|
Sciclone Pharmaceuticals Inc SCLN
Common Stock
|
2016-09-29 | Option exercise | 7,648 | $5.10 | 39,005 |
|
Sciclone Pharmaceuticals Inc SCLN
Common Stock
|
2016-09-29 | Option exercise | 33,333 | $5.22 | 173,998 |
|
Sciclone Pharmaceuticals Inc SCLN
Common Stock
|
2016-08-30 | Sell | 7,540 | $10.33 | 77,888 |
| showing 20 of 31 most recent transactions | |||||